Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Myeloid Leukemia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01667133
What this trial is testing

Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Chronic Myeloid Leukemia (CML)Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Ariad Pharmaceuticals 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04258943
What this trial is testing

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

Who this might be right for
Philadelphia Chromosome Positive CMLAccelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous Leukemia+1 more
Children's Oncology Group 60
Not applicableNo Longer AvailableNCT04518644
What this trial is testing

Nilotinib, for Patients With CML-CP or CML-AP

Who this might be right for
Chronic Myelogenous Leukemia (CML)
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT00004009
What this trial is testing

R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
University of Maryland, Baltimore
Not applicableEnded earlyNCT00008216
What this trial is testing

Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Adult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more
Columbia University 48
Testing effectiveness (Phase 2)Ended earlyNCT00005984
What this trial is testing

Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 22
Early research (Phase 1)Study completedNCT03886831
What this trial is testing

PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

Who this might be right for
Relapsed/Refractory Advanced Solid TumorsRelapsed/Refractory Diffuse Large B-cell LymphomaRelapsed/Refractory Myelodysplasia+5 more
Prelude Therapeutics Incorporated 232
Not applicableLooking for participantsNCT07763054
What this trial is testing

Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome+6 more
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine 30
Early research (Phase 1)Study completedNCT00017472
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma, Acute Lymphoblastic Leukemia, or Acute Myeloid Leukemia

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaNoncontiguous Stage II Marginal Zone Lymphoma+11 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Ended earlyNCT01773395
What this trial is testing

GVAX vs. Placebo for MDS/AML After Allo HSCT

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Dana-Farber Cancer Institute 123
Early research (Phase 1)Study completedNCT00809250
What this trial is testing

Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome-Refractory Anemia With Excess Blasts
Dana-Farber Cancer Institute 33
Testing effectiveness (Phase 2)Study completedNCT01083706
What this trial is testing

Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+9 more
Fred Hutchinson Cancer Center 43
Early research (Phase 1)WithdrawnNCT03807063
What this trial is testing

Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant

Who this might be right for
Acute Bilineal LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm, Unclassifiable+9 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Large-scale testing (Phase 3)Ended earlyNCT01827930
What this trial is testing

Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular Response

Who this might be right for
Leukemia, Myeloid, Chronic-Phase
Institut Bergonié 68
Testing effectiveness (Phase 2)WithdrawnNCT01011998
What this trial is testing

Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)

Who this might be right for
Chronic Myelogenous Leukemia
New Mexico Cancer Research Alliance
Early research (Phase 1)Study completedNCT00710528
What this trial is testing

Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Lymphoma, Non-Hodgkin (NHL)Acute Myeloid Leukemia (AML)+1 more
Gilead Sciences 192
Not applicableStudy completedNCT05734053
What this trial is testing

Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 222
Early research (Phase 1)Study completedNCT00351975
What this trial is testing

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Who this might be right for
Accelerated Phase of DiseaseAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+17 more
National Cancer Institute (NCI) 56
Next Page